Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Y-3”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableLooking for participantsNCT06374667
What this trial is testing

The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction

Who this might be right for
Stroke, Acute IschemicBlood-Brain Barrier
yilong Wang 134
Early research (Phase 1)Study completedNCT07068841
What this trial is testing

Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants

Who this might be right for
Pharmacokinetic ProfilesY-3 for InjectionDrug-drug Interaction+4 more
Neurodawn Pharmaceutical Co., Ltd. 24
Not applicableStudy completedNCT05849805
What this trial is testing

Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)

Who this might be right for
Stroke, Acute Ischemic
Beijing Tiantan Hospital 20
Early research (Phase 1)Not Yet RecruitingNCT07055412
What this trial is testing

Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects

Who this might be right for
Pharmacokinetic DifferencesY-3Saftey+3 more
Neurodawn Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT06429384
What this trial is testing

Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial

Who this might be right for
Acute Ischemic Stroke
Beijing Tiantan Hospital 240
Early research (Phase 1)Study completedNCT06770491
What this trial is testing

Y-3 in US Healthy Volunteers.

Who this might be right for
SafetyTolerabilityPharmacokinetic Study in Healthy Volunteers
Neurodawn Pharmaceutical Co., Ltd. 20
Large-scale testing (Phase 3)Looking for participantsNCT06517173
What this trial is testing

Y-3 for Injection in the Treatment of Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Beijing Tiantan Hospital 998